Home › Drug Codes › J Codes › G0138 · POMBILITI and OPFOLDA
Updated September 9th, 2026

POMBILITI and OPFOLDA J Code: G0138

Intravenous infusion of cipaglucosidase alfa-atga, including provider/supplier acquisition and clinical supervision of oral administration of miglustat in preparation of receipt of cipaglucosidase alfa-atga

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
$650.50
/ HCPCS billing unit · APC 1508
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
—
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Intravenous infusion of cipaglucosidase alfa-atga, including provider/supplier acquisition and clinical supervision of oral administration of miglustat in preparation of receipt of cipaglucosidase alfa-atga
HCPCS Added Date April 1, 2024
Manufacturer Amicus
Generic Status Multi-Source; Generic

About POMBILITI and OPFOLDA

G0138 is an administration code for the intravenous infusion of Pombiliti combined with the oral administration of Opfolda

Manufacturers, reach out to us to add more information.

NDC Code Information

No NDC packages are aligned to G0138 in publicly available CMS files.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
No public NDC alignments
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →
Not on the CMS JW / JZ list

CMS does not include POMBILITI and OPFOLDA (G0138) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing G0138. Wastage billing guide →

POMBILITI and OPFOLDA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Late-onset Pompe disease

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is a Pombiliti and Opfolda billing and coding guide available?
Our team has not identified a manufacturer-published source of billing and coding information for POMBILITI and OPFOLDA.
Is Pombiliti and Opfolda patient assistance information available?
POMBILITI and OPFOLDA patient assistance information can be found through Amicus. Visit Here →
Where can I find Pombiliti and Opfolda prescribing information?
Our team is still working to identify a source of prescribing information for G0138
Where can I find Pombiliti and Opfolda side effect information?
Our team is still working to identify a source of side effect information for G0138
Does billing POMBILITI and OPFOLDA require JZ/JW wastage modifiers?
CMS does not include POMBILITI and OPFOLDA (G0138) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing G0138. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.